PIPELINE
진행상황
| Pipeline | 치료분야 | 적응증 |
전임상
임상1상
임상2상
임상3상
|
|
|---|---|---|---|---|
|
RGN-259
|
Ophthalmic Disease 안과질환치료
|
Dry Eye Disease (안구건조증, DED)
|
|
|
| 희귀의약품 rare diseases | Neurotrophic Keratopathy (신경영양성각막염, NK) |
|
||
| OKN-007 | Brain Cancer 뇌종양치료 | Glioblastoma multiforme (교모세포종, GBM) 신규 진단 환자 연구자 임상 |
|
|
| Glioblastoma multiforme (교모세포종, GBM) 재발 환자 임상 |
|
|||
- DED (Dry Eye Disease, 안구건조증) 임상명 : ARISE (A Phase III Study of RGN-259 Identifying Safety and Efficacy)
- NK (Neurotrophic Keratopathy, 신경영양성각막염) 임상명 : SEER (Safety and Efficacy Examination of RGN-259)